Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2003
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/16/2003US6664294 Compounds which have excellent antimicrobial activity, even at very low concentrations, and which is retained in presence of salt-containing media, such as saline solutions
12/16/2003US6664286 Lower and control elevated intraocular pressure
12/16/2003US6664252 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
12/16/2003US6664224 Quaternary ammonium salt and process for the preparation thereof
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR
12/11/2003WO2003101490A1 Drug composition containing calcium channel antagonist
12/11/2003WO2003101466A1 Rubrofusarin glycoside-containing composition
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101379A2 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof
12/11/2003WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2002089853A3 Compositions having enhanced pharmacokinetic characteristics
12/11/2003WO2002065943A3 Ocular tear growth factor-like protein
12/11/2003US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders
12/11/2003US20030229145 Analgesics; amino acid drug
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229078 Prevent apoptosis; vision defects; central nervous system disorders; antiischemic agents; stroke therapy
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229055 Methods of simultaneously treating ocular rosacea and acne rosacea
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228359 Antiallergen mixture
12/11/2003US20030228299 Using superoxide dismutase
12/11/2003US20030228277 Reduce concentration of reactive oxygen metabolites
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2486832A1 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369409A1 Process for preparing compounds useful as intermediates
12/10/2003EP1369127A1 Novel medicinal use of aplpha antigen or alpha antigen gene
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368309A2 Thiol-modified hyaluronan
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP1368013A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1460469A Preparation method of aspirin microsphere
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/10/2003CN1130195C Nanoemulsion based on ethoxylated fatty ether or ethoxylated fatty ester, and use thereof
12/09/2003US6660870 Serotonergic compounds which possess agonist activity at 5-HT2 receptors effectively lower and control normal and elevated IOP and are useful for treating glaucoma
12/09/2003US6660757 Use of riluzole in the treating acoustic traumas
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003US6660297 Nutritional supplement to treat macular degeneration
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099813A1 Novel physiolgically active substances
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 531